Compare SRTS & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRTS | LFT |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | 60 | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 58.2M |
| IPO Year | 2016 | N/A |
| Metric | SRTS | LFT |
|---|---|---|
| Price | $3.19 | $1.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 72.2K | ★ 137.2K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 18.49% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,482,000.00 | N/A |
| Revenue This Year | $2.00 | $668.15 |
| Revenue Next Year | $34.23 | N/A |
| P/E Ratio | ★ N/A | $13.49 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.82 | $1.04 |
| 52 Week High | $5.92 | $2.65 |
| Indicator | SRTS | LFT |
|---|---|---|
| Relative Strength Index (RSI) | 34.42 | 39.13 |
| Support Level | $3.03 | $1.04 |
| Resistance Level | $3.53 | $1.40 |
| Average True Range (ATR) | 0.26 | 0.05 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 23.97 | 37.50 |
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.